(Q38177450)

30 August 2017

title

Reducing waste from incomplete or unusable reports of biomedical research (English)

1 reference

30 August 2017

4

1 reference

30 August 2017

8

1 reference

30 August 2017

9

1 reference

30 August 2017

2

Douglas G Altman

0 references

Susan Michie

object named as

Susan Michie

series ordinal

7

0 references

Paul P. Glasziou

object named as

Paul Glasziou

series ordinal

1

0 references

Patrick Bossuyt

series ordinal

3

object named as

Patrick Bossuyt

1 reference

30 August 2017

5

Mike Clarke

1 reference

30 August 2017

Steven Julious

6

1 reference

30 August 2017

language of work or name

English

0 references

publication date

8 January 2014

1 reference

30 August 2017

1 reference

30 August 2017

volume

383

1 reference

30 August 2017

issue

9913

1 reference

30 August 2017

page(s)

267-276

1 reference

The secret lives of experiments: methods reporting in the fMRI literature

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962228-X

7 January 2021

How many scientists fabricate and falsify research? A systematic review and meta-analysis of survey data

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962228-X

7 January 2021

Avoidable waste in the production and reporting of research evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962228-X

7 January 2021

Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962228-X

7 January 2021

Publishing clinical trial results: the future beckons

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962228-X

7 January 2021

Does use of the CONSORT Statement impact the completeness of reporting of randomised controlled trials published in medical journals? A Cochrane review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962228-X

7 January 2021

Increasing value and reducing waste: addressing inaccessible research

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962228-X

7 January 2021

Published methodological quality of randomized controlled trials does not reflect the actual quality assessed in protocols

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962228-X

7 January 2021

What is missing from descriptions of treatment in trials and reviews?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962228-X

7 January 2021

Summaries of findings, descriptions of interventions, and information about adverse effects would make reviews more informative

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962228-X

7 January 2021

Adequacy of published oncology randomized controlled trials to provide therapeutic details needed for clinical application.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962228-X

7 January 2021

Inadequate description of educational interventions in ongoing randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962228-X

7 January 2021

Quality and reporting of diagnostic accuracy studies in TB, HIV and malaria: evaluation using QUADAS and STARD standards

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962228-X

7 January 2021

Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962228-X

7 January 2021

Survey of the quality of experimental design, statistical analysis and reporting of research using animals

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962228-X

7 January 2021

Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962228-X

7 January 2021

Poor quality of reporting confounding bias in observational intervention studies: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962228-X

7 January 2021

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962228-X

7 January 2021

STrengthening the REporting of Genetic Association Studies (STREGA): an extension of the STROBE statement

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962228-X

7 January 2021

Reporting and methods in clinical prediction research: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962228-X

7 January 2021

Reporting recommendations for tumor marker prognostic studies (REMARK).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962228-X

7 January 2021

Strengthening the reporting of Genetic RIsk Prediction Studies: the GRIPS Statement

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962228-X

7 January 2021

Reporting guidelines for survey research: an analysis of published guidance and reporting practices

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962228-X

7 January 2021

Inaccessible novel questionnaires in published medical research: hidden methods, hidden costs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962228-X

7 January 2021

Use of qualitative methods alongside randomised controlled trials of complex healthcare interventions: methodological study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962228-X

7 January 2021

Effective techniques in healthy eating and physical activity interventions: a meta-regression.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962228-X

7 January 2021

Press releases by academic medical centers: not so academic?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962228-X

7 January 2021

How reliable is science information on the web?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962228-X

7 January 2021

The quality of diagnostic accuracy studies since the STARD statement: Has it improved?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962228-X

7 January 2021

Reporting of eligibility criteria of randomised trials: cohort study comparing trial protocols with subsequent articles

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962228-X

7 January 2021

Reporting of participant flow diagrams in published reports of randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962228-X

7 January 2021

Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): explanation and elaboration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962228-X

7 January 2021

Systematic review of the empirical evidence of study publication bias and outcome reporting bias

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962228-X

7 January 2021

Reporting bias in drug trials submitted to the Food and Drug Administration: review of publication and presentation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962228-X

7 January 2021

Bias in reporting of end points of efficacy and toxicity in randomized, clinical trials for women with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962228-X

7 January 2021

MicroRNA Molecular Profiles Associated with Diagnosis, Clinicopathologic Criteria, and Overall Survival in Patients with Resectable Pancreatic Ductal Adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962228-X

7 January 2021

Time-dependent bias was common in survival analyses published in leading clinical journals.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962228-X

7 January 2021

Developing risk prediction models for type 2 diabetes: a systematic review of methodology and reporting

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962228-X

7 January 2021

Better reporting of harms in randomized trials: an extension of the CONSORT statement

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962228-X

7 January 2021

Reporting of adverse events in systematic reviews can be improved: survey results

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962228-X

7 January 2021

Graphical literacy: the quality of graphs in a large-circulation journal.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962228-X

7 January 2021

Reporting and interpretation of randomized controlled trials with statistically nonsignificant results for primary outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962228-X

7 January 2021

Overinterpretation and misreporting of diagnostic accuracy studies: evidence of "spin".

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962228-X

7 January 2021

Financial ties and concordance between results and conclusions in meta-analyses: retrospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962228-X

7 January 2021

Scope and impact of financial conflicts of interest in biomedical research: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962228-X

7 January 2021

Author disclosure of conflict of interest in vascular surgery journals

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962228-X

7 January 2021

CONSORT for reporting randomized controlled trials in journal and conference abstracts: explanation and elaboration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962228-X

7 January 2021

Effect of editors' implementation of CONSORT guidelines on the reporting of abstracts in high impact medical journals: interrupted time series analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962228-X

7 January 2021

Methods of blinding in reports of randomized controlled trials assessing pharmacologic treatments: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962228-X

7 January 2021

Writing a research article that is "fit for purpose": EQUATOR Network and reporting guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962228-X

7 January 2021

Effect of using reporting guidelines during peer review on quality of final manuscripts submitted to a biomedical journal: masked randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962228-X

7 January 2021

ExaCT: automatic extraction of clinical trial characteristics from journal publications

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962228-X

7 January 2021

Inadequate post-publication review of medical research

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962228-X

7 January 2021

Unjustified restrictions on letters to the editor

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962228-X

7 January 2021

A systematic examination of the citation of prior research in reports of randomized, controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962228-X

7 January 2021

Citation bias of hepato-biliary randomized clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962228-X

7 January 2021

Reference bias in reports of drug trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962228-X

7 January 2021

Persistence of contradicted claims in the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962228-X

7 January 2021

The case for structuring the discussion of scientific papers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962228-X

7 January 2021

Structuring the discussion of scientific papers. Results of single studies must be assessed in context of relevant systematic reviews

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962228-X

7 January 2021

Clinical trials should begin and end with systematic reviews of relevant evidence: 12 years and waiting

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962228-X

7 January 2021

Putting research into context--revisited

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962228-X

7 January 2021

Guidelines for reporting health care research: advancing the clarity and transparency of scientific reporting

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962228-X

7 January 2021

Scientific Utopia: II. Restructuring Incentives and Practices to Promote Truth Over Publishability

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962228-X

7 January 2021

Proposed best practice for statisticians in the reporting and publication of pharmaceutical industry-sponsored clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962228-X

7 January 2021

Making available information from studies sponsored by the pharmaceutical industry: some current practices

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962228-X

7 January 2021

Trial Registration at ClinicalTrials.gov between May and October 2005

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962228-X

7 January 2021

Why prospective registration of systematic reviews makes sense

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962228-X

7 January 2021

The nuts and bolts of PROSPERO: an international prospective register of systematic reviews

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962228-X

7 January 2021

CONSORT 2010 Statement: Updated guidelines for reporting parallel group randomised trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962228-X

7 January 2021

Guidance for developers of health research reporting guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962228-X

7 January 2021

The quality of reporting of trial abstracts is suboptimal: survey of major general medical journals.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962228-X

7 January 2021

10.1016/S0140-6736(13)62228-X

Identifiers

DOI

1 reference

30 August 2017

1 reference